Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04217759
Other study ID # UBDIHS/13H0621
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date February 27, 2018

Study information

Verified date January 2020
Source Universiti Brunei Darussalam
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The general research question posed was 'How effective is a healthy lifestyle intervention using behavioural change strategies in the prevention of Type 2 Diabetes Mellitus (T2DM)?'.

The main aim was to assess the effectiveness of a healthy lifestyle intervention implemented for 12 weeks via face-to-face group sessions and by using social media tools (Facebook and WhatsApp) for young adults at risk of T2DM.

The hypothesis was that this healthy lifestyle intervention may be effective in terms of initiating an increased physical activity (PA) level and a healthy balanced dietary intake resulting in improvements of other T2DM risk factors at 12 weeks.


Description:

The specific research question posed was 'Is a healthy lifestyle intervention using Social Cognitive Theory (SCT)-based PA and dietary strategies implemented for 12 weeks through face-to-face group sessions and social media tools effective in the initiation and maintenance of increased PA level and healthy balanced dietary intake, resulting in improvements of T2DM risk score, anthropometrics, metabolic parameters and SCT-related psychosocial factors among Bruneian young adults at risk of T2DM?'.

Study design was two-arm parallel, stratified with simple randomisation, and assessor-blinded randomised controlled trial. Participants were randomly allocated into intervention group and control group. Participants were students and alumni of Universiti Brunei Darussalam and Universiti Teknologi Brunei who were overweight-obese at risk of T2DM with a mean age of 23.1 (2.48) years old. Intervention group went through a healthy lifestyle intervention using evidence-based SCT strategies emphasising on PA and diet for 12 weeks, while the control group only received leaflets on healthy lifestyle with no further guidance. Outcomes measured were changes from baseline at week 0 to post-intervention at week 13 between intervention and control groups. Outcomes were changes in diabetes risk score, anthropometrics, metabolic parameters, PA, dietary intake and SCT-related psychosocial factors, with repeated-measures ANOVA as the main analysis.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date February 27, 2018
Est. primary completion date February 27, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria:

- Bruneian including permanent residents

- BMI from 25.00 to 39.99 kg/m2

- American Diabetes Association (ADA) diabetes risk score of at least 3 and maximum score of 8

- Mentally and physically fit with no chronic conditions

- Without medical conditions that could influence glucose metabolism and insulin resistance

- Answered 'No' to all 6 questions in questionnaire-based pre-exercise risk assessment

- Not actively participating in other healthy lifestyle programmes

- Had access to computer or mobile phone with Internet

Study Design


Intervention

Behavioral:
Healthy lifestyle intervention
The main goal was to provide knowledge and skills for targeted population in order for them to adapt healthy lifestyle throughout their life. At the end of intervention, participants were expected to be fully equipped with necessary knowledge and fundamental skills in adapting and maintaining healthy lifestyle throughout their life. Gradual improvements were emphasised and at least 5% loss of initial body weight was expected, aiming for at least 0.5% loss in the first month. It was divided into three phases (preparation, implementation, maintenance) focusing on PA and diet, in which self-efficacy enhancement and self-regulatory skills were emphasised during the first month of intervention.

Locations

Country Name City State
Brunei Darussalam PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam Brunei Bandar Seri Begawan

Sponsors (1)

Lead Sponsor Collaborator
Universiti Brunei Darussalam

Country where clinical trial is conducted

Brunei Darussalam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in diabetes risk score from week 0 to week 13 Using Finnish Diabetes Risk Score (FINDRISC) questionnaire, with minimum score of 0 and maximum score of 22. Score less than 7 as low risk, 7 to 11 as slightly elevated, 12 to 14 as moderate risk, 15 to 20 as high risk and more than 20 as very high risk. 12 weeks
Secondary Change in weight (kg) Using digital weighing scale 12 weeks
Secondary Change in weight (%) Using digital weighing scale 12 weeks
Secondary Height in cm Using digital weighing scale At baseline
Secondary Change in body mass index (BMI) (kg/m2) Calculated with weight and height 12 weeks
Secondary Change in waist circumference (WC) (cm) Measured at the midpoint between the lower border of the ribcage and iliac crest with tape measure 12 weeks
Secondary Change in hip circumference (HC) (cm) Measured at the largest portion of the buttocks with tape measure 12 weeks
Secondary Change in waist-to-hip ratio (WHR) Calculated with WC and HC 12 weeks
Secondary Change in fasting blood glucose (FBG) (mmol/l) With finger-pricking and AccuTrend Plus System blood analyses 12 weeks
Secondary Change in fasting blood total cholesterol (TC) (mmol/l) With finger-pricking and AccuTrend Plus System blood analyses 12 weeks
Secondary Change in fasting blood triglycerides (TG) (mmol/l) With finger-pricking and AccuTrend Plus System blood analyses 12 weeks
Secondary Change in systolic blood pressure (SBP) (mmHg) Using OMRON automated blood pressure monitor 12 weeks
Secondary Change in diastolic blood pressure (DBP) (mmHg) Using OMRON automated blood pressure monitor 12 weeks
Secondary Change in resting heart rate (pulse/min) Using OMRON automated blood pressure monitor 12 weeks
Secondary Change in vigorous PA metabolic task (MET) (min/week) Using short-form international PA questionnaire (SF-IPAQ) 12 weeks
Secondary Change in moderate PA MET (min/week) Using SF-IPAQ 12 weeks
Secondary Change in walking MET (min/week) Using SF-IPAQ 12 weeks
Secondary Change in total PA MET (min/week) Using SF-IPAQ 12 weeks
Secondary Change in sitting time (hrs/day) Using SF-IPAQ 12 weeks
Secondary Change in intake of carbohydrates (servings/day) Using 4-day dietary record 12 weeks
Secondary Change in intake of protein (servings/day) Using 4-day dietary record 12 weeks
Secondary Change in intake of fruits (servings/day) Using 4-day dietary record 12 weeks
Secondary Change in Intake of vegetables (servings/day) Using 4-day dietary record 12 weeks
Secondary Change in intake of water in (litres/day) Using 4-day dietary record 12 weeks
Secondary Change in motivation score Using University of Rhode Island Change Assessment (URICA) with minimum score of -2 and maximum score of 14. The higher the score, the higher the motivation. 12 weeks
Secondary Change in social support (diet) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better support for eating healthy. 12 weeks
Secondary Change in social support (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better support for exercising 12 weeks
Secondary Change in overcoming barriers (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more capabilities to overcome barriers towards exercising 12 weeks
Secondary Change in moral disengagement (diet) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate lack of control in eating 12 weeks
Secondary Change in outcome expectations (diet) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more positive expectations for dieting 12 weeks
Secondary Change in outcome expectations (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more positive expectations for exercising 12 weeks
Secondary Change in emotional coping (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better emotional coping by exercising 12 weeks
Secondary Change in self-efficacy (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better confidence in exercising 12 weeks
Secondary Facilitation (PA) score Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better access to facilities and equipment for exercising 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2